When the FDA reclassified interbody fusion devices in 2007, the C-Ti was the first such device to be cleared and now it is the first interbody fusion device to be cleared as an anterior cervical plate.
Read RSB Spine’s release on FDA approval of its InterPlate C-Ti.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
